Pharmacokinetic and Safety Study With Adalimumab in Chinese Subjects With Mild Rheumatoid Arthritis

Inclusion Criteria: * Male or Female ages 18 years and older. * Mild RA. * Body weight less than 100 kg. Exclusion Criteria: * Wheelchair-bound or bedridden. * Joint surgery involving joints to be assessed within this study, within two months prior to the Screening visit. * Intra-articular, intramuscular or intravenous (IV) administration of corticosteroids within 28 days prior to the Screening visit. * Prior treatment with any TNF antagonist, including adalimumab. * Positive tuberculin PPD 5. * Female subjects who are pregnant or breast-feeding. * History of HIV or of being immuno-compromised. * History of malignancy. * Poorly controlled medical condition.